Editorial: Biomarkers of Alzheimer’s Disease: The Present and the Future

per Lehmann, Sylvain, Teunissen, Charlotte Elisabeth
Publicat a Front Neurol (2016)

New CSF biomarkers on the block

per Teunissen, Charlotte E, Parnetti, Lucilla
Publicat a EMBO Mol Med (2016)

Iron and Neurodegeneration in Multiple Sclerosis

per Khalil, Michael, Teunissen, Charlotte, Langkammer, Christian
Publicat 2011

Concatenating plasma p-tau to Alzheimer’s disease

per Tijms, Betty M, Teunissen, Charlotte E
Publicat a Brain (2021)

Contactins in the central nervous system: role in health and disease

per Chatterjee, Madhurima, Schild, Detlev, Teunissen, Charlotte E.
Publicat a Neural Regen Res (2019)

Critical Steps to be Taken into Consideration Before Quantification of β-Amyloid and Tau Isoforms in Blood can be Implemented in a Clinical Environment

per Vanderstichele, Hugo Marcel, Teunissen, Charlotte E., Vanmechelen, Eugeen
Publicat a Neurol Ther (2019)

Plasma p-tau217: from ‘new kid’ to most promising candidate for Alzheimer’s disease blood test

per Teunissen, Charlotte E, Thijssen, Elisabeth H, Verberk, Inge M W
Publicat a Brain (2020)

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

per Bertens, Daniela, Tijms, Betty M., Scheltens, Philip, Teunissen, Charlotte E., Visser, Pieter Jelle
Publicat a Alzheimers Res Ther (2017)

Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?

per Del Campo Milan, Marta, Zuroff, Leah, Jimenez, Connie R., Scheltens, Philip, Teunissen, Charlotte E.
Publicat a Alzheimers Dement (Amst) (2015)

The plasma peptides of Alzheimer’s disease

per Florentinus-Mefailoski, Angelique, Bowden, Peter, Scheltens, Philip, Killestein, Joep, Teunissen, Charlotte, Marshall, John G.
Publicat a Clin Proteomics (2021)

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β ((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop

per Teunissen, Charlotte E., Verwey, Niek A., Kester, Maartje I., van Uffelen, Kees, Blankenstein, Marinus A.
Publicat 2010

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

per Cicognola, Claudia, Hansson, Oskar, Scheltens, Philip, Kvartsberg, Hlin, Zetterberg, Henrik, Teunissen, Charlotte E., Blennow, Kaj
Publicat a Alzheimers Res Ther (2021)

Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables

per Vuletic, Simona, Kennedy, Hal, Albers, John J., Killestein, Joep, Vrenken, Hugo, Lütjohann, Dieter, Teunissen, Charlotte E.
Publicat 2014

gMS-Classifier1 does not predict disability progression in multiple sclerosis

per van Rossum, Johannis A, Killestein, Joep, Villar, Luisa M, Riskind, Peter N, Freedman, Mark S, Teunissen, Charlotte
Publicat a Mult Scler (2018)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

per van Steenoven, Inger, van der Flier, Wiesje M., Scheltens, Philip, Teunissen, Charlotte E., Lemstra, Afina W.
Publicat a Alzheimers Res Ther (2019)

Facilitating the Validation of Novel Protein Biomarkers for Dementia: An Optimal Workflow for the Development of Sandwich Immunoassays

per del Campo, Marta, Jongbloed, Wesley, Twaalfhoven, Harry A. M., Veerhuis, Robert, Blankenstein, Marinus A., Teunissen, Charlotte E.
Publicat a Front Neurol (2015)

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes

per Pijnenburg, Yolande A.L., Verwey, Nicolaas A., van der Flier, Wiesje M., Scheltens, Philip, Teunissen, Charlotte E.
Publicat a Alzheimers Dement (Amst) (2015)

Effect of long-term storage in biobanks on cerebrospinal fluid biomarker Aβ(1-42), T-tau, and P-tau values

per Willemse, Eline A.J., van Uffelen, Kees W.J., van der Flier, Wiesje M., Teunissen, Charlotte E.
Publicat a Alzheimers Dement (Amst) (2017)

Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types

per Vereyken, Elly JF, Heijnen, Priscilla DAM, Baron, Wia, de Vries, Elga HE, Dijkstra, Christine D, Teunissen, Charlotte E
Publicat 2011

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal

per Vermunt, Lisa, van Paasen, Alegría J.L., Teunissen, Charlotte E., Scheltens, Philip, Visser, Pieter Jelle, Tijms, Betty M.
Publicat a Neurology (2019)